SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-215331
Filing Date
2019-08-07
Accepted
2019-08-07 16:12:10
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d770319d10q.htm   iXBRL 10-Q 2134072
2 EX-10.1 d770319dex101.htm EX-10.1 19739
3 EX-31.1 d770319dex311.htm EX-31.1 10766
4 EX-31.2 d770319dex312.htm EX-31.2 10749
5 EX-32.1 d770319dex321.htm EX-32.1 5965
11 GRAPHIC g770319g72g45.jpg GRAPHIC 2302
  Complete submission text file 0001193125-19-215331.txt   6617983

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20190630.xsd EX-101.SCH 30980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20190630_cal.xml EX-101.CAL 43729
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20190630_def.xml EX-101.DEF 130371
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20190630_lab.xml EX-101.LAB 313389
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20190630_pre.xml EX-101.PRE 245796
12 EXTRACTED XBRL INSTANCE DOCUMENT d770319d10q_htm.xml XML 1213123
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 191005585
SIC: 2834 Pharmaceutical Preparations